Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Contributes of genetic testing to understanding the aetiology of sudden cardiac arrest: 4-year experience of genetic laboratory
Session:
Sessão de Posters 28 - Morte súbita cardíaca
Speaker:
Susana Lemos Ferreira
Congress:
CPC 2024
Topic:
C. Arrhythmias and Device Therapy
Theme:
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
Subtheme:
08.4 Ventricular Arrhythmias and SCD - Treatment
Session Type:
Cartazes
FP Number:
---
Authors:
Susana Lemos Ferreira; Inês Custódio Santos; Rafael Graça; Catarina Silveira; Yuri Chiodo; Maria do Carmo-Fonseca; Diana Antunes
Abstract
<p style="text-align:justify">Background: Sudden cardiac arrest (SCA) at a young age can be the first manifestation of an underlying genetic disorder, namely an inheritable primary arrhythmia, a cardiomyopathy, an aortopathy or other hereditary cardiac disease (HCD). The combined prevalence of HCD can be high as 1:200 and globally represents 15-20% death causes in developed countries, affecting in particularly males under 50 years of age. Genetic testing is essential for establishing an aetiology and providing personalize follow-up and adequate family screening. Our previous works revealed an overall 21.37% genetic diagnosis (GD) rate (N=209) from a total of 978 genetic analysis performed for confirmed or suspected HCD in our laboratory. </p> <p style="text-align:justify">Aim: Identify and characterise cases of SCA or sudden cardiac death (SCD) that underwent a genetic testing. Compare the GD rate of the individuals tested with direct family history of SCA/SCD with the overall GD previously obtained to further validate this variable as a relevant marker of HCD. </p> <p style="text-align:justify">Methods: Retrospective review of the results of genetic testing performed in both probands for SCA/ SCD or probands with suspected HCD and direct family history of SCD from 2019 until 2023 and calculation of their respectively GD rate. </p> <p style="text-align:justify">Results: A total of 32 genetic analyses were carried out for individuals referred for SCA or SCD. From the total of these cases, after subsequent clinical evaluation, it was identified an underlying disease in 20 cases of SCA: primary arrhythmia syndrome (6), cardiomyopathy (5) and congenital cardiopathy (1). A (likely) pathogenic variant was found in 5 samples on <em>TPM1, DSP, DSC2, RYR2, TTN </em>genes with a diagnostic yield of 16%. </p> <p style="text-align:justify">Additionally, we reviewed further 77 genetic analyses performed for individuals with suspected or confirmed HCD where there was a direct family history of SCD: 36 cases of hypertrophic cardiomyopathy, 20 dilated cardiomyopathy, 1 arrhythmogenic right ventricular cardiomyopathy, 12 unspecified cardiomyopathy, 6 primary arrhythmia syndrome, 1 familial hypercholesterolemia, and 1 coronary artery disease. A (likely) pathogenic variant was found in 21 cases, namely on <em>MYH7</em> (4), <em>MYBPC3</em> (4), <em>LMNA</em> (3), <em>TTN</em> (2), <em>FBN1</em> (1), <em>TPM1</em> (1), <em>FHOD3 </em>(1), <em>TTR</em> (1), <em>LAMA2 </em>(1), <em>FLNC</em> (1), <em>RYR2</em> (1), <em>DSP </em>(1) genes, with a diagnostic yield of 27%. </p> <p style="text-align:justify">Our results revealed a higher GD rate in the cohort of individuals with a family history of SCD, validating the relevance </p> <p style="text-align:justify">Conclusions: This work aims to add further evidence on the utility of genetic testing on case of SCA/SCD and validate that protocols of investigation of SCA/SCD should include performing routinely genetic analysis, performed in a multidisciplinary setting. Given that many cases result of HCD only identifying an underlying genetic cause can allow patients and their relatives an adequate management and screening of at-risk relatives. </p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site